NS · Healthcare

Fredun Pharmaceuticals Ltd (539730)

Pharmaceuticals & Biotechnology

Fredun Pharmaceuticals Ltd (539730) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $13.73B, P/E ratio is 41.33, net margin is 4.8%, dividend yield is 0.03%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 539730

Market cap

$13.73B

P/E ratio

41.33

Net margin

4.8%

Dividend yield

0.03%

Fredun Pharmaceuticals Ltd (539730) — FAQ

What is Fredun Pharmaceuticals Ltd's market cap?

Fredun Pharmaceuticals Ltd (539730) has a reported market cap of $13.73B (data as of 2026-07-10).

What is 539730's P/E ratio?

The price-to-earnings (P/E) ratio for Fredun Pharmaceuticals Ltd (539730) is 41.33 (data as of 2026-07-10).

Does Fredun Pharmaceuticals Ltd pay a dividend?

Fredun Pharmaceuticals Ltd (539730) shows a reported dividend yield of 0.03%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Fredun Pharmaceuticals Ltd in?

Fredun Pharmaceuticals Ltd (539730) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 539730 listed on?

539730 is listed on NS.

What is Fredun Pharmaceuticals Ltd's net margin?

Fredun Pharmaceuticals Ltd (539730) reports a net margin of 4.8% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)